Cardiac optogenetics: the next frontier. Issue 12 (5th January 2018)

• Record Type: Journal Article
• Authors: Gruber, Amit; Edri, Oded; Gepstein, Lior
• Is Part Of: Europace. Volume 20:Issue 12(2018)
• Page Start: 1910
• Page End: 1918
• Publication Date: 2018-01-05
• Subjects: Optogenetics -- Opsins -- Arrhythmias -- Pacing -- Defibrillation; Arrhythmia -- Treatment -- Periodicals; Cardiac pacing -- Periodicals; Catheter ablation -- Periodicals; Heart -- Physiology -- Periodicals; Electrophysiology -- Periodicals; 617.4120645
• DOI: 10.1093/europace/eux371
• Languages: English
• ISSNs: 1099-5129

Abstract

Abstract: The emerging technology of optogenetics uses optical and genetic means to monitor and modulate the electrophysiological properties of excitable tissues. While transforming the field of neuroscience, the technology has recently gained popularity also in the cardiac arena. Here, we describe the basic principles of optogenetics, the available and evolving optogenetic tools, and the unique potential of this technology for basic and translational cardiac electrophysiology. Specifically, we discuss the ability to control (augment or suppress) the cardiac tissue's excitable properties using optogenetic actuators (microbial opsins), which are light-gated ion channels and pumps that can cause light-triggered membrane depolarization or hyperpolarization. We then focus on the potential clinical implications of this technology for the treatment of cardiac arrhythmias by describing recent efforts for developing optogenetic-based cardiac pacing, resynchronization, and defibrillation experimental strategies. Finally, the significant obstacles and challenges that need to be overcome before any future clinical translation can be expected are discussed.